Archive

02 August 2020, Volume 36 Issue 8 Previous Issue    Next Issue

---

For Selected:

Download Citations EndNote Ris BibTeX

Toggle Thumbnails

Select

Establishment and clinical application of fetal growth curve. CHEN Jian-ping，SUN Lu-ming 2020, 36(8): 685-688.  DOI: 10.19538/j.fk2020080104 Abstract ( )   The review introduces the establishment of different fetal growth curves commonly used in the world and the applicable population，and compares their clinical value in screening for small-for-gestational-age fetuses as well as in predicting adverse perinatal outcomes. It is recommended to build suitable fetal growth curve to improve the screening sensitivity for small -for-gestation-age fetuses，help predict adverse perinatal outcomes, and provide guidance for the monitoring and management of pregnancy，which is of great significance in reducing perinatal death and the related complications.

Select

Etiological discussion of fetal growth restriction. TONG Jia-ning，NIU Jian-min 2020, 36(8): 688-692.  DOI: 10.19538/j.fk2020080105 Abstract ( )   Fetal growth restriction is a multifactorial syndrome，involving maternal，placental，fetal and genetic factors.With the development of molecular biology，genetic factors become an important etiological factor；moreover，some metabolic and endocrine factors can also lead to fetal growth restriction.Early diagnosis of fetal growth restriction can identify the condition etiologically and the fetal status can be monitored adequately，and thereby minimizing the risk of various complications，so it is of great importance for us to understand the etiological factors deeply.

Select

Screening of fetal growth restriction. ZHENG Ming-ming，HU Ya-li 2020, 36(8): 692-695.  DOI: 10.19538/j.fk2020080106 Abstract ( )   Fetal growth restriction（FGR） endangers fetal health and survival，which is increasingly concerned by perinatal clinicians. The screening of FGR helps to strengthen monitoring for high-risk pregnant women and reduce late pregnancy stillbirth and neonatal death. This article reviews the significance，methods and progress of FGR screening.

Select

Clinical diagnosis of fetal growth restriction. TAN Hu，CHEN Dun-jin 2020, 36(8): 695-698.  DOI: 10.19538/j.fk2020080107 Abstract ( )   Fetal growth restriction（FGR）means that the fetus does not reach its biological growth potential due to impaired placental function caused by a variety of factors.FGR is one of important causes of perinatal death and other adverse outcomes.Ultrasound evaluation of fetal growth and development is crucial for clinical diagnosis of FGR.Once FGR is diagnosed during the pregnancy，the classification should be performed based on the time of onset and the potential etiology（especially structural abnormalities）since they are closely associated with the prognosis.This helps to provide better clinical treatment and management and to reduce the risk of adverse maternal and fetal outcomes.

Select

Evaluation of different intrauterine monitoring methods for fetal growth restriction. WU Yan-xin，WANG Zi-lian 2020, 36(8): 698-702.  DOI: 10.19538/j.fk2020080108 Abstract ( )   Fetal growth restriction not only is an important cause of perinatal morbidity and death，but may also have an adverse effect on its growth and development in the long term.Therefore，it is very important to strengthen the monitoring of FGR fetuses，especially to dynamically evaluate their intrauterine growth and oxygen supply，which can provide guidance for finding fetal abnormalities and taking timely treatment measures.This article focuses on the commonly used monitoring methods of intrauterine fetuses and evaluates the value in clinical practice.

Select

Prevention and treatment of fetal growth restriction. WANG Xie-tong，LIU Jing 2020, 36(8): 702-706.  DOI: 10.19538/j.fk2020080109 Abstract ( )   In high risk women for fetal growth restriction，healthy diet and balanced energy and protein supplementation reduce the risk of small-for-gestational-age infant.Supplementation of multiple micronutrients in malnourished mothers may reduce the incidence of low-birth-weight and small-for-gestational-age infant.Low-dose aspirin can reduce the risk of fetal growth restriction.Whether low molecular heparin can prevent fetal growth restriction needs further study，but no serious adverse reactions of low molecular heparin have been observed.Once the diagnosis of fetal growth restriction is confirmed，no treatment will improve fetal growth.There is no evidence that bed rest，nutritional supplementation，oxygen therapy or volume expansion has therapeutic effect on fetal growth restriction，and there is no clear evidence that low molecular heparin plays a role in the treatment of fetal growth restriction；however，potential therapies aiming at improving poor uteroplacental perfusion are under research，such as nitrate supplementation，beta-agonists，sildenafil，hydrogen sulfide，statins and melatonin.

Select

Timing and route of delivery for pregnancy with fetal growth restriction. SHENG Chao，WANG Zhi-jian 2020, 36(8): 706-709.  DOI: 10.19538/j.fk2020080110 Abstract ( )   Fetal growth restriction（FGR）is a major factor contributing to the perinatal morbidity and mortality.Based on the FGR guidelines and expert consensus of China，the USA，GB，Canada，France，New Zealand and Ireland and with reference to the latest clinical researches，this review summarizes the timing and route of delivery for pregnancy with FGR.

Select

Effects of fetal growth restriction on perinatal  outcome and long-term health. JUAN Juan，YANG Hui-xia 2020, 36(8): 710-713.  DOI: 10.19538/j.fk2020080111 Abstract ( )   Fetal growth restriction is likely to cause fetal distress，neonatal asphyxia，and other adverse perinatal outcomes，and it also affects the occurrence and development of various chronic non-infectious diseases in adulthood，which poses a serious threat to perinatal and long-term health.It is necessary to strengthen the monitoring of fetal growth and pay more attention to health care of early life，which has a profound impact on the health of entire life cycle.